Alterações secundárias no covid-19: uma revisão bibliográfica
DOI:
https://doi.org/10.34024/rnc.2022.v30.12370Palavras-chave:
Covid-19, Coronavírus, Manifestações neurológicasResumo
Introdução. O surto da nova doença de coronavírus (COVID-19) na China se espalhou pelo mundo, tornando-se uma emergência de grande preocupação internacional. O novo coronavírus pertence às espécies β dos coronavírus, que são transmitidos principalmente através de gotículas respiratórias. Podendo os sintomas da infecção envolver vários sistemas, incluindo respiratório, gastrointestinal, musculoesquelético e neurológico. Objetivo. Relatar a percepção de alterações secundárias de pacientes com infecção por SARS-CoV-2 em aspectos neurológicos, cognitivos e funcionais. Método. Trata-se de uma revisão bibliográfica, com busca nas bases de dados PubMed e Science Direct, entre o período de abril de 2020 e maio de 2021. Resultados. A presença dos distúrbios gustativos e olfativos se apresentaram em 5 dos estudos examinados, além de outros sintomas mais comuns como a cefaleia e tontura. Sobre a Síndrome de Guillain-Barré (SGB), quatro dos estudos analisados apresentaram casos de pacientes com diagnóstico de SGB e SARS-CoV-2, mostrando uma possível associação entre as patologias, assim como no acidente vascular cerebral. Conclusão. As manifestações neurológicas apresentaram ocorrência frequente no curso da doença. Com grande parte destas alterações acontecendo em estágios iniciais da infecção, ocorrendo ou não em conjunto aos sintomas típicos da infecção. Podendo até mesmo serem as únicas manifestações da infecção, bem como, serem as responsáveis por maiores complicações no quadro clínico dos pacientes.
Downloads
Métricas
Referências
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265-9. https://doi.org/10.1038/s41586-020-2008-3
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 2020;92:441-7. https://doi.org/10.1002/jmv.25689
Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020;295:685-91. https://doi.org/10.1148/radiol.2020200463
Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology 2020;296:E113-14. https://doi.org/10.1148/radiol.2020200527
Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care 2020;24:28. https://doi.org/10.1186/s13054-020-2738-5
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue distribution, hostvirus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995-8. https://doi.org/10.1021/acschemneuro.0c00122
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3
Desforges M, Coupanec AL, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses 2019;12:14. https://doi.org/10.3390/v12010014
Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 2020;13:1-2. https://doi.org/10.1177/1756286420917830
Yin R, Feng W, Wang T, Chen G, Wu T, Chen D, et al. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019. J Med Virol 2020;92:1782-4. https://doi.org/10.1002/jmv.25888
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20. https://doi.org/10.1056/NEJMoa2002032
Pellitero SE, Ferrer-Bergua LG. Report of a Patient With Neurological Symptoms as the Sole Manifestation of SARS-CoV-2 Infection. Neurologia 2020;35:271-2. https://doi.org/10.1016/j.nrl.2020.04.010
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;10:e201127. https://doi.org/10.1001/jamaneurol.2020.1127
Helms J, Kremer S, Merdji H, Jehl RC, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020;382:2268-70. https://doi.org/10.1056/NEJMc2008597
Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun 2020;87:115-9. https://doi.org/10.1016/j.bbi.2020.04.077
Tunç A, Ünlübaş Y, Alemdar M, Akyüz E. Coexistence of Covid-19 and Acute Ischemic Stroke Report of Four Cases. J Clin Neurosci 2020;77:227-9. https://doi.org/10.1016/j.jocn.2020.05.018
Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 2020;78:109-12. https://doi.org/10.1016/j.seizure.2020.04.009
Sohal S, Mossammat M. COVID-19 Presenting with Seizures. IDCases 2020;20:1-2. https://doi.org/10.1016/j.idcr.2020.e00782
Lechien JR, Chiesa-Estomba CM, Siati DR, Horoi M, Bom SDL, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020;277:2251-61. https://doi.org/10.1007/s00405-020-05965-1
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383-4. https://doi.org/10.1016/S1474-4422(20)30109-5
Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 2020;7:1-5. https://doi.org/10.1212/NXI.0000000000000741
Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 2020;76:233-5. https://doi.org/10.1016/j.jocn.2020.04.062
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;12:e7352. https://doi.org/10.7759/cureus.7352
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology 2020;296:E119-20. https://doi.org/10.1148/radiol.2020201187
Meppiel E, Smadja N, Maury A, Bekri I, Delorme C, Desestret V, et al. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infec 2021;27:458-66. https://doi.org/10.1016/j.cmi.2020.11.005
Altunisik E, Sayiner HS, Aksoz S, Cil E, Ozgenc G. Neurological symptoms in COVID-19 patients. Bratisl Med J 2021;122:39-44. https://doi.org/10.4149/BLL_2021_004
Silva FDF, Grimshaw MG, Ferrer SIV, Hernández APV, Moreno RD, Samaniego DPT, et al. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS One 2021;16:e0247433. https://doi.org/10.1371/journal.pone.0247433
Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Vernetti PM, et al. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology 2021;96:e575-86. https://doi.org/10.1212/WNL.0000000000010979
Zain S, Petropoulou K, Mirchia K, Hussien A, Mirchia K. COVID-19 as a rare cause of facial nerve neuritis in a pediatric patient. Radiol Case Rep 2021;16:1400-4. https://doi.org/10.1016/j.radcr.2021.03.063
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Katriele Neri Lima, Aline Ferreira Cavalcante Souza, Ana Paula Rodrigues Camargo, Diogo Pereira Cardoso de Sá
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Aceito: 2021-10-05
Publicado: 2022-02-09
Português
English
Español
